Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

SPDR Gold Trust (ETF) (GLD): The One Asset That Is Vulnerable to Fed “Tapering”

Although we don’t believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes — just in case they’re material to our investing thesis.

The anticipation is almost over, as the Federal Open Market Committee’s September meeting gets underway today. However, we’ll need to wait until tomorrow to find out the outcome of Fed policymakers’ deliberations. Will they begin to pare back the central bank’s monthly bond purchases? And if they do, by what amount? Those are the questions market participants of all stripes are mulling over.

Perhaps that cocktail of anticipation and reflection is keeping the market’s natural propensity toward momentum in check this morning, as the S&P 500 and the narrower, price-weighted Dow Jones Industrial Average are up just 0.33% each as of 10:10 a.m. EDT.

More than stocks or bonds, gold looks vulnerable

Barring a curve ball from the Fed, I’m not expecting much of a reaction from the stock or bond markets at the outcome of the FOMC meeting. Gold, on the other hand — whether in the physical market or in exchange-traded vehicles such as the SPDR Gold Trust (ETF) (NYSEMKT:GLD) — certainly looks vulnerable if the Fed begins curtailing its quantitative-easing program, a.k.a. QE.


After all, goldbugs are convinced that QE has become a permanent feature of the financial landscape, necessary to propping up a bankrupt money system. Witnessing the Fed withdrawing its monetary largesse, rather than increasing it, ought to rattle that worldview (although goldbugs are nothing if not stubborn).

However, regardless of whether the Fed decides to taper QE this month, the next, or even early next year, I will repeat what I wrote last Friday:

The longer-term outlook for gold is not favorable. … Although the Fed has said it does not expect to raise its policy rate until 2015, real interest rates will increase in the years to come. … The benchmark 10-year bond yield has already shown it has that capacity this summer, and as rates normalize, they’ll sound the death knell for gold — and you can take that to the bank.

That view is consistent with the one articulated by Goldman Sachs‘ Damien Courvalin and Jeffrey Currie in a note published yesterday: “Our economists’ outlook for accelerating U.S. growth late in the year (2013), clearly above-trend growth and a less accommodative monetary policy stance in 2014 remain the key driver to our bearish outlook for gold prices into 2014.”

Indeed, interest rates will normalize as the Fed withdraws from the bond market and economic growth and growth expectations increase. Goldman expects gold to fall to $1,050 by the end of next year, but I think setting price targets on such a short time frame is nonsense; still, the longer-term trend ought to be clear. According to Bloomberg News, holdings in gold-backed exchange-traded products declined by 1.1 metric tons yesterday to 1,939.2 tons — the lowest since May 2010. The average price of gold in that month was $1,205.43 per ounce.

The article The One Asset That Is Vulnerable to Fed “Tapering” originally appeared on and is written by Alex Dumortier, CFA.

Fool contributor Alex Dumortier, CFA has no position in any stocks mentioned; you can follow him on LinkedIn. The Motley Fool has no position in any of the stocks mentioned. 

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!